J van Beek1, A A van der Eijk2, P L A Fraaij2, K Caliskan2, K Cransberg2, M Dalinghaus2, R A S Hoek2, H J Metselaar2, J Roodnat2, H Vennema3, M P G Koopmans4. 1. Erasmus Medical Center, Rotterdam, The Netherlands; National Institute of Public Health and the Environment, Bilthoven, The Netherlands. 2. Erasmus Medical Center, Rotterdam, The Netherlands. 3. National Institute of Public Health and the Environment, Bilthoven, The Netherlands. 4. Erasmus Medical Center, Rotterdam, The Netherlands; National Institute of Public Health and the Environment, Bilthoven, The Netherlands. Electronic address: m.koopmans@erasmusmc.nl.
Abstract
OBJECTIVES: Immunocompromised patients can suffer prolonged norovirus symptoms and virus shedding for many years. Little is known about the prevalence of chronic norovirus infection among solid organ transplant (SOT) recipients. In this study, 2182 SOT recipients were retrospectively tested for chronic norovirus infection. METHODS: The first and last norovirus positive faecal samples of SOT recipients were sequenced to distinguish between persisting infection and re-infection. Patient charts were reviewed to obtain data on health status and treatments. RESULTS: In all, 101 of 2182 (4.6%) recipients were norovirus infected and 23 (22.8%) of these developed chronic norovirus infection. Chronic norovirus infection was found among allogeneic heart, kidney and lung transplant recipients. The median shedding period at the end of the study period was 218 days (range 32-1164 days). CONCLUSIONS: This study shows that chronic norovirus infection is not a rare phenomenon among SOT recipients in a tertiary-care hospital. Further research is needed to study the risk of norovirus transmission to other immunocompromised patients in the hospital and to the general population.
OBJECTIVES: Immunocompromised patients can suffer prolonged norovirus symptoms and virus shedding for many years. Little is known about the prevalence of chronic norovirus infection among solid organ transplant (SOT) recipients. In this study, 2182 SOT recipients were retrospectively tested for chronic norovirus infection. METHODS: The first and last norovirus positive faecal samples of SOT recipients were sequenced to distinguish between persisting infection and re-infection. Patient charts were reviewed to obtain data on health status and treatments. RESULTS: In all, 101 of 2182 (4.6%) recipients were norovirus infected and 23 (22.8%) of these developed chronic norovirus infection. Chronic norovirus infection was found among allogeneic heart, kidney and lung transplant recipients. The median shedding period at the end of the study period was 218 days (range 32-1164 days). CONCLUSIONS: This study shows that chronic norovirus infection is not a rare phenomenon among SOT recipients in a tertiary-care hospital. Further research is needed to study the risk of norovirus transmission to other immunocompromised patients in the hospital and to the general population.
Authors: Wen Dang; Yuebang Yin; Yijin Wang; Wenshi Wang; Junhong Su; Dave Sprengers; Luc J W van der Laan; Krzysztof Felczak; Krzysztof W Pankiewicz; Kyeong-Ok Chang; Marion P G Koopmans; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191
Authors: Westyn Branch-Elliman; Roger V Araujo-Castillo; Graham M Snyder; Bernadette F Sullivan; Carolyn D Alonso; Sharon B Wright Journal: Infect Control Hosp Epidemiol Date: 2020-02-24 Impact factor: 3.254
Authors: M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild Journal: Ann Hematol Date: 2017-11-24 Impact factor: 3.673
Authors: Gregorius J Sips; Mariëlle J G Dirven; Joke T Donkervoort; Francien M van Kolfschoten; Claudia M E Schapendonk; My V T Phan; Annemieke Bloem; Anna F van Leeuwen; Mariechristine E Trompenaars; Marion P G Koopmans; Annemiek A van der Eijk; Miranda de Graaf; Ewout B Fanoy Journal: Zoonoses Public Health Date: 2020-02-09 Impact factor: 2.702
Authors: Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Boyd Yount; Matthew H Collins; Kari Debbink; Rachel L Graham; Ralph S Baric Journal: J Virol Date: 2019-01-04 Impact factor: 5.103